Gattermann N - Search Results

1

The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence.

Bruns I, Czibere A, Fischer JC, Roels F, Cadeddu RP, Buest S, Bruennert D, Huenerlituerkoglu AN, Stoecklein NH, Singh R, Zerbini LF, Jäger M, Kobbe G, Gattermann N, Kronenwett R, Brors B, Haas R. Bruns I, et al. Among authors: gattermann n. Leukemia. 2009 May;23(5):892-9. doi: 10.1038/leu.2008.392. Epub 2009 Jan 22. Leukemia. 2009. PMID: 19158832

2

Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.

Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Aul C, et al. Among authors: gattermann n. Leukemia. 1992 Jan;6(1):52-9. Leukemia. 1992. PMID: 1736014

3

Detection of the ageing-associated 5-Kb common deletion of mitochondrial DNA in blood and bone marrow of hematologically normal adults. Absence of the deletion in clonal bone marrow disorders.

Gattermann N, Berneburg M, Heinisch J, Aul C, Schneider W. Gattermann N, et al. Leukemia. 1995 Oct;9(10):1704-10. Leukemia. 1995. PMID: 7564514

4

Fatal hyperleukocytic syndrome in a patient with chronic myelomonocytic leukemia.

Aul C, Gattermann N, Germing U, Südhoff T, Hollmig KA, Heyll A. Aul C, et al. Among authors: gattermann n. Leuk Res. 1997 Mar;21(3):249-53. doi: 10.1016/s0145-2126(96)00117-8. Leuk Res. 1997. PMID: 9111170

5

Increasing incidence of myelodysplastic syndromes: real or fictitious?

Aul C, Germing U, Gattermann N, Minning H. Aul C, et al. Among authors: gattermann n. Leuk Res. 1998 Jan;22(1):93-100. doi: 10.1016/s0145-2126(97)00089-1. Leuk Res. 1998. PMID: 9585086

6

Problems in the classification of CMML--dysplastic versus proliferative type.

Germing U, Gattermann N, Minning H, Heyll A, Aul C. Germing U, et al. Among authors: gattermann n. Leuk Res. 1998 Oct;22(10):871-8. doi: 10.1016/s0145-2126(97)00192-6. Leuk Res. 1998. PMID: 9766745

7

[Role of aggressive treatment strategies for myelodysplastic syndromes].

Aul C, Germing U, Minning H, Kobbe G, Gattermann N, Südhoff T, Meckenstock G, Söhngen D, Heyll A. Aul C, et al. Among authors: gattermann n. Praxis (Bern 1994). 1999 Mar 4;88(10):431-8. Praxis (Bern 1994). 1999. PMID: 10199215 Review. German.

8

Long-term remission after intensive chemotherapy in advanced myelodysplastic syndromes is generally associated with restoration of polyclonal haemopoiesis.

Aivado M, Rong A, Germing U, Gattermann N, Kobbe G, Rieth C, Haas R, Aul C. Aivado M, et al. Among authors: gattermann n. Br J Haematol. 2000 Sep;110(4):884-6. doi: 10.1046/j.1365-2141.2000.02302.x. Br J Haematol. 2000. PMID: 11054075 Free article.

9

Pericardial effusion in chronic myelomonocytic leukemia (CMML): a case report and review of the literature.

Strupp C, Germing U, Trommer I, Gattermann N, Aul C. Strupp C, et al. Among authors: gattermann n. Leuk Res. 2000 Dec;24(12):1059-62. doi: 10.1016/s0145-2126(00)00078-3. Leuk Res. 2000. PMID: 11077120 Review.

10

Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma.

Misgeld E, Germing U, Aul C, Gattermann N. Misgeld E, et al. Among authors: gattermann n. Leuk Res. 2001 Jan;25(1):95-98. doi: 10.1016/s0145-2126(00)00092-8. Leuk Res. 2001. PMID: 11137566

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters